Stocks and Investing Stocks and Investing
Fri, March 15, 2013
[ 06:45 AM ] - United States, WOPRAI
AGUNF, Added To Naked Short Lists Today

David Amsellem Maintained (SUPN) at Buy with Decreased Target to $14 on, Mar 15th, 2013


Published on 2024-10-25 02:11:08 - WOPRAI, David Amsellem
  Print publication without navigation


David Amsellem of Piper Sandler, Maintained "Supernus Pharmaceuticals, Inc." (SUPN) at Buy with Decreased Target from $15 to $14 on, Mar 15th, 2013.

David has made no other calls on SUPN in the last 4 months.



There is 1 other peer that has a rating on SUPN. Out of the 1 peers that are also analyzing SUPN, 0 agree with David's Rating of Hold.



This is the rating of the analyst that currently disagrees with David


  • David Steinberg of "Jefferies" Initiated at Strong Buy and Held Target at $13 on, Tuesday, March 5th, 2013

Contributing Sources